Cargando…
Current Perspectives in the Treatment of Locally Advanced Basal Cell Carcinoma
Basal cell carcinoma (BCC) is the most common cancer in Caucasians, and its incidence continues to rise. Generally, BCCs have good outcomes when diagnosed and treated early. However, 1–10% of patients will develop advanced disease due to either delays in accessing treatment or aggressive tumors that...
Autores principales: | Gupta, Neha, Ruiz, Emily S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765439/ https://www.ncbi.nlm.nih.gov/pubmed/35058688 http://dx.doi.org/10.2147/DDDT.S325852 |
Ejemplares similares
-
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives
por: Heppt, Markus V., et al.
Publicado: (2022) -
Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
por: Mastronardi, Luis, et al.
Publicado: (2021) -
Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma
por: Tampa, Mircea, et al.
Publicado: (2021) -
Sonidegib treatment in patients with locally advanced basal cell carcinoma
por: Villani, Alessia, et al.
Publicado: (2022) -
Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
por: García Ruiz, Antonio J, et al.
Publicado: (2022)